Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression (DAL)
NCT: NCT05840185 · TERMINATED
Brief Summary
This is a mono-centre, prospective, one-arm, unmask clinical trial to evaluate the effectiveness of test lens in slowing myopia progression with respect to axial length elongation compared to a single vision spectacle lens from the historical control group of another clinical trial NCT05331378. A total of 40 children will be recruited
Frequently Asked Questions
What is Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression (DAL)?
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression (DAL) is a clinical trial registered under NCT05840185. Current status: TERMINATED.
What is the status of NCT05840185?
The current status of NCT05840185 (Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression (DAL)) is: TERMINATED.
When did Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression (DAL) start?
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression (DAL) started on 2023-08-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.